Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Revista
Tipo del documento
Intervalo de año de publicación
1.
Elife ; 92020 04 09.
Artículo en Inglés | MEDLINE | ID: mdl-32271147

RESUMEN

Phosphate overload contributes to mineral bone disorders that are associated with crystal nephropathies. Phytate, the major form of phosphorus in plant seeds, is known as an indigestible and of negligible nutritional value in humans. However, the mechanism and adverse effects of high-phytate intake on Ca2+ and phosphate absorption and homeostasis are unknown. Here, we show that excessive intake of phytate along with a low-Ca2+ diet fed to rats contributed to the development of crystal nephropathies, renal phosphate wasting, and bone loss through tubular dysfunction secondary to dysregulation of intestinal calcium and phosphate absorption. Moreover, Ca2+ supplementation alleviated the detrimental effects of excess dietary phytate on bone and kidney through excretion of undigested Ca2+-phytate, which prevented a vicious cycle of intestinal phosphate overload and renal phosphate wasting while improving intestinal Ca2+ bioavailability. Thus, we demonstrate that phytate is digestible without a high-Ca2+ diet and is a risk factor for phosphate overloading and for the development of crystal nephropathies and bone disease.


Asunto(s)
Huesos/metabolismo , Calcio de la Dieta/efectos adversos , Calcio/metabolismo , Minerales/metabolismo , Alimentación Animal/análisis , Animales , Dieta/efectos adversos , Femenino , Masculino , Fosfatos , Fósforo/metabolismo , Ácido Fítico/farmacología , Ratas Sprague-Dawley , Insuficiencia Renal Crónica/metabolismo , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA